Explore: The Journal of Science and Healing
Volume 6, Issue 1 , Pages 47-51 , January 2010

Integrative Men's Nutrition

References 

  1. Centers for Disease Control and Prevention. Men's health. http://www.cdc.gov/menAccessed October 6, 2009
  2. Lichtenstein A, Appel L, Brands M, et al. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation. 2006;114:82–96
  3. Fito M, Guxens M, Corella D, et al. Effect of a traditional Mediterranean diet on lipoprotein oxidation. Arch Int Med. 2007;167:1195–1203
  4. Panagiotakos D. Mediterranean diet lowers C-reactive protein levels. In: Abstract presented at American Heart Association Scientific Sessions. Orlando. November 2003;
  5. Hu FB, Willett WC. Optimal diets for prevention of coronary heart disease. JAMA. 2002;288:2569–2578
  6. O'Keefe JH, Gheewala NM, O'Keefe JO. Dietary strategies for improving post-pranidal glucose, lipids, inflammation and cardiovascular health. J Am Coll Cardiol. 2008;51:249–255
  7. Mente A, de Koning L, Shannon HS, Anand SS. A sytematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med. 2009;169:659–669
  8. Dansinger ML, Gleason JA, Griffith JL, Selker HP, Schaefer EJ. Comparison of the Atkins, Ornish, Weight Watchers, and Zone Diets for weight loss and heart disease risk reduction: a randomized trial. JAMA. 2005;293:43–53
  9. Psota T, Gebauer S, Kris-Etherton P. Dietary omega-3 fatty acid intake and cardiovascular risk. Am J Cardiol. 2006;8:3–18
  10. Dietary supplementation with omega-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet. 1999;354:447–455
  11. Harper CR, Jacobson TA. The fats of life: the role of omega-3 fatty acids in the prevention of coronary heart disease. Arch Intern Med. 2001;161:2185–2192
  12. Gouni-Berthold I, Krone W, Berthold HK. Vitamin D and cardiovascular disease. Curr Vasc Pharmacol. 2009;7:414–422
  13. Lee JH, O'Keefe JH, Bell D, Hensrud DD, Holick MF. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor?. J Am Coll Cardiol. 2008;52:1949–1956
  14. Ohira T, Peacock JM, Iso H, et al. Serum and dietary magnesium and risk of ischemic stroke—the Atherosclerosis Risk in Communities Study (A prospective study of total and ionized serum calcium and fatal prostate cancer). Am Jnl Epi. 2009;12:1437–1444
  15. American Heart Association Science Advisory. Homosysteine, diet and cardiovascular diseases. Circulation. 1999;99:178–182
  16. Jenkins DJ, Kendall CW, Marchie A, et al. Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein. JAMA. 2003;290:502–510
  17. Heber D, Yip I, Ashley JM, Elashoff DA, Elashoff RM. Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement. Am J Clin Nutr. 1999;69:231–236
  18. Miettinen TA, Puska P, Gylling H, Vanhanen H, Vartiainen E. Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population. N Engl J Med. 1995;333:1308–1312
  19. Illingworth DR, Stein EA, Mitchel YB, et al. Comparative effects of lovastatin and niacin in primary hypercholesterolemia (A prospective trial). Arch Intern Med. 1994;154:1586–1595
  20. Andersson SO, Wolk A, Bergstrom R, et al. Body size and prostate cancer: a 20-year follow-up study among 135,006 Swedish construction workers. J Natl Cancer Inst. 1997;89:385–389
  21. Aziz NM, Hartman T, Barrett M, et al. Weight and prostate cancer in the Alpha-Tocopherol Beta-Carotene Cancer Prevention (ATBC) Trial. 2000 ASCO Annual Meeting, Atlanta, GA, 19, 647a.
  22. King IB, Kristal AR, Schaffer S, Thornquist M, Goodman GE. Serum trans-fatty acids are associated with risk of prostate cancer in beta-carotene and retinol efficacy trial. Cancer Epidemiol Biomarkers Prev. 2005;14:988–992
  23. National Cancer Institute. Prostate cancer prevention (PDQ). http://www.cancer.gov/cancertopics/pdq/prevention/prostate/patient/allpagesAccessed October 6, 2009
  24. Lipman SA, Klein EA, Goodman PJ, et al. Effect of selenium and vitamin e on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2009;301:39–51
  25. Cohen JH, Kristal AR, Stanford JL. Fruit and vegetable intakes and prostate cancer risk. J Natl Cancer Inst. 2000;92:61–68
  26. Pantuck AJ, Leppert JT, Zomorodian N, et al. Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer. Clin Cancer Res. 2006;12:4018–4026
  27. Giovannucci E, Rimm EB, Wolk A. A prospective study of calcium intake and incident and fatal prostate cancer. Cancer Epidemiol Biomarkers Prev. 2006;15:203–210
  28. Skinner HG, Schwartz GG. Cancer Epidemiol Biomarkers Prev. 2009;18:575–578Epub 3 February 2009
  29. Gao X, LaValley MP, Tucker KL. Prospective studies of dairy product and calcium intakes and prostate cancer risk: a meta-analysis. J Natl Cancer Inst. 2005;97:1768–1777
  30. Simon JA, Chen Yea-Hung, Bent S, et al. The relation of alpha-linolenic acid to the risk of prostate cancer: a systematic review and meta-analysis. Am J Clin Nutr. 2009;89:1558S–1564S
  31. Boehm K, Borrelli F, Ernst E, et al. Green tea (Camellia sinensis) for the prevention of cancer. Cochrane Database Syst Rev. 2009;(3):CD005004
  32. Hussain M, Banerjee M, Sarkar FH, et al. Soy isoflavones in the treatment of prostate cancer. Nutr Cancer. 2003;47:111–117
  33. Messina MJ, Persky V, Setchell KD. Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr Cancer. 1994;21:113–131
  34. Berry SJ, Coffey DS, Walsh PC, et al. The development of human benign prostatic hyperplasia with age. J Urol. 1984;132:474
  35. Boyle P, Robertson C, Lowe F, Roehrborn C. Meta-analysis of clinical trials of permixon in the treatment of symptomatic benign prostatic hyperplasia. Urology. 2000;55:533–539
  36. Kristal AR, Arnold KB, Schenk JM, et al. Dietary patterns, supplement use and the risk of symptomatic BPH: results from the Prostate Cancer Prevention Trial. Am J Epidemiol. 2008;167:925–934
  37. Wilt T, Ishani A. Pgeum africanum for benign prostatic hyperplasia. Cochrane Database Syst Rev. 2002;(1):CD001044
  38. Norat T, Bingham S, Ferrari P. Meat, fish, and colorectal cancer risk: the European Prospective Investigation into cancer and nutrition. J Natl Cancer Inst. 2005;97:906–916
  39. Bingham SA, Day NE, Luben R, et al. Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study. Lancet. 2003;361:1496–1501
  40. Fleischauer AT, Arab L. Garlic and cancer: a critical review of the epidemiologic literature. J Nutr. 2001;131(3s):1032S–1040S
  41. Ngo SNT, Williams DB, Cobiac L, Head RJ. “Does garlic reduce risk of colorectal cancer?” (A systematic review). J Nutr. 2007;137:2264–2269
  42. In:  Abrams D,  Weil A editor. Integrative Oncology. New York: Oxford University Press; 2009;p. 444
  43. Ng K, Meyerhardt JA, Wu K, et al. Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer. J Clin Oncol. 2008;26:2984–2991
  44. Prasad AS, Mantzoros CS, Beck FW, et al. Zinc status and serum testosterone levels of healthy adults. Nutrition. 1996;12:344–348
  45. Rimbach G, Minihane AM. Nutrigenetics and personalised nutrition: how far have we progressed and are we likely to get there?. Proc Nutr Soc. 2009;68:162–172

PII: S1550-8307(09)00365-6

doi: 10.1016/j.explore.2009.11.001

Explore: The Journal of Science and Healing
Volume 6, Issue 1 , Pages 47-51 , January 2010

Article Tools